Hyaluronic Acid Fillers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Pages: 89 Published: May 20, 2022 Report Code: GDME1364EPD

Hyaluronic Acid (HA) is a glycosaminoglycan disaccharide, which exists naturally in the body. GlobalData's Medical Devices sector report, “Hyaluronic Acid Fillers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Hyaluronic Acid Fillers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Hyaluronic Acid Fillers report provides key information and data related to:

Extensive coverage of the Hyaluronic Acid Fillers under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Hyaluronic Acid Fillers pipeline products.

Review of Recent Developments in the segment / industry

The Hyaluronic Acid Fillers report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Hyaluronic Acid Fillers under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Hyaluronic Acid Fillers under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Hyaluronic Acid Fillers and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

– Identify and understand important and diverse types of Hyaluronic Acid Fillers under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Players

Allergan Aesthetics

Almirall Ltd

BioPlus Co Ltd

BMG Pharma SpA

Bmi Korea Co Ltd

CellPraxis

Collplant Biotechnologies Ltd

Fillmed Laboratoires

Genzyme Corp

Hallura Ltd

Hugel Inc

LG Chem Ltd

LifeSprout Inc

Medytox Inc

Merz North America Inc

Mesoestetic Pharma Group SL

Oligo Medic Inc

Q-Med AB

Revance Therapeutics Inc

Shanghai Haohai Biological Technology Co Ltd

Shin Poong Pharm Co Ltd

Silk Medical Aesthetics Inc

Sinclair Pharma Ltd

Teoxane SA

Tissueform Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 9

2 Introduction 10

2.1 Hyaluronic Acid Fillers Overview 10

3 Products under Development 11

3.1 Hyaluronic Acid Fillers – Pipeline Products by Stage of Development 11

3.2 Hyaluronic Acid Fillers – Pipeline Products by Segment 12

3.3 Hyaluronic Acid Fillers – Pipeline Products by Territory 13

3.4 Hyaluronic Acid Fillers – Pipeline Products by Regulatory Path 14

3.5 Hyaluronic Acid Fillers – Pipeline Products by Estimated Approval Date 15

3.6 Hyaluronic Acid Fillers – Ongoing Clinical Trials 16

4 Hyaluronic Acid Fillers – Pipeline Products under Development by Companies 17

4.1 Hyaluronic Acid Fillers Companies – Pipeline Products by Stage of Development 17

4.2 Hyaluronic Acid Fillers – Pipeline Products by Stage of Development 19

5 Hyaluronic Acid Fillers Companies and Product Overview 21

5.1 Allergan Aesthetics Company Overview 21

5.1.1 Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 21

5.2 Almirall Ltd Company Overview 27

5.2.1 Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

5.3 BioPlus Co Ltd Company Overview 28

5.3.1 BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

5.4 BMG Pharma SpA Company Overview 31

5.4.1 BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview 31

5.5 Bmi Korea Co Ltd Company Overview 33

5.5.1 Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

5.6 CellPraxis Company Overview 34

5.6.1 CellPraxis Pipeline Products & Ongoing Clinical Trials Overview 34

5.7 Collplant Biotechnologies Ltd Company Overview 35

5.7.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 35

5.8 Fillmed Laboratoires Company Overview 36

5.8.1 Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview 36

5.9 Genzyme Corp Company Overview 41

5.9.1 Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview 41

5.10 Hallura Ltd Company Overview 42

5.10.1 Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

5.11 Hugel Inc Company Overview 46

5.11.1 Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.12 LG Chem Ltd Company Overview 50

5.12.1 LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

5.13 LifeSprout Inc Company Overview 58

5.13.1 LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview 58

5.14 Medytox Inc Company Overview 61

5.14.1 Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview 61

5.15 Merz North America Inc Company Overview 63

5.15.1 Merz North America Inc Pipeline Products & Ongoing Clinical Trials Overview 63

5.16 Mesoestetic Pharma Group SL Company Overview 66

5.16.1 Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview 66

5.17 Oligo Medic Inc Company Overview 67

5.17.1 Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview 67

5.18 Q-Med AB Company Overview 68

5.18.1 Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview 68

5.19 Revance Therapeutics Inc Company Overview 71

5.19.1 Revance Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 71

5.20 Shanghai Haohai Biological Technology Co Ltd Company Overview 72

5.20.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 72

5.21 Shin Poong Pharm Co Ltd Company Overview 73

5.21.1 Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 73

5.22 Silk Medical Aesthetics Inc Company Overview 74

5.22.1 Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 74

5.23 Sinclair Pharma Ltd Company Overview 78

5.23.1 Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 78

5.24 Teoxane SA Company Overview 81

5.24.1 Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview 81

5.25 Tissueform Inc Company Overview 84

5.25.1 Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview 84

6 Hyaluronic Acid Fillers- Recent Developments 85

6.1 Nov 17, 2021: Silk Medical Aesthetics announces feasibility clinical trial results for its all-natural dermal filler 85

7 Appendix 86

7.1 Methodology 86

7.2 About GlobalData 89

7.3 Contact Us 89

7.4 Disclaimer 89

List of Tables

Hyaluronic Acid Fillers – Pipeline Products by Stage of Development 11

Hyaluronic Acid Fillers – Pipeline Products by Segment 12

Hyaluronic Acid Fillers – Pipeline Products by Territory 13

Hyaluronic Acid Fillers – Pipeline Products by Regulatory Path 14

Hyaluronic Acid Fillers – Pipeline Products by Estimated Approval Date 15

Hyaluronic Acid Fillers – Ongoing Clinical Trials 16

Hyaluronic Acid Fillers Companies – Pipeline Products by Stage of Development 17

Hyaluronic Acid Fillers – Pipeline Products by Stage of Development 19

Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 21

HA Threads – Product Status 21

HA Threads – Product Description 21

Juvederm Voluma – Nose – Product Status 22

Juvederm Voluma – Nose – Product Description 22

Juvederm Voluma – Temple – Product Status 22

Juvederm Voluma – Temple – Product Description 23

Juvederm Voluma Global – Malar Augmentation – Product Status 23

Juvederm Voluma Global – Malar Augmentation – Product Description 23

Allergan Aesthetics – Ongoing Clinical Trials Overview 24

Juvederm Voluma Global – Malar Augmentation – A Prospective, Multi-center, Randomized, Controlled, Single-blind Study of the Safety and Effectiveness of Algeness DF 3.5% Deep Volumizing Filler to Correct Age-related Volume Deficit in the Mid-face 25

Juvederm Voluma Global – Malar Augmentation – Clinical, Instrumental and Histological Evaluation of the Combined Use of Onabotulinumtoxin A and Hyaluronic Acid Fillers in Patients with Facial Paralysis 25

Juvederm Voluma – Temple – A Multicenter, Evaluator-blinded, Randomized, No-treatment Controlled Study to Evaluate the Safety and Effectiveness of Juvederm Voluma with Lidocaine for Correction of Temple Hollowing in Chinese Population 26

Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

Hyaluronic Acid Facial Filler – Product Status 27

Hyaluronic Acid Facial Filler – Product Description 27

BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

Biological Breast – Product Status 28

Biological Breast – Product Description 28

Hyaluronic Acid Filler – Bio-cartilage Replacement – Product Status 29

Hyaluronic Acid Filler – Bio-cartilage Replacement – Product Description 29

Hyaluronic Acid Filler – Bladder Tissue Repair – Product Status 29

Hyaluronic Acid Filler – Bladder Tissue Repair – Product Description 30

BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview 31

SGA300 – Product Status 31

SGA300 – Product Description 31

SGA302 – Product Status 32

SGA302 – Product Description 32

Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

BMI4002 – Product Status 33

BMI4002 – Product Description 33

CellPraxis Pipeline Products & Ongoing Clinical Trials Overview 34

Lipage – Product Status 34

Lipage – Product Description 34

Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 35

Dermal Filler – Product Status 35

Dermal Filler – Product Description 35

Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview 36

ART FILLER FINE LINES – Product Status 36

ART FILLER FINE LINES – Product Description 36

ART FILLER LIPS – Product Status 37

ART FILLER LIPS – Product Description 37

ART FILLER LIPS SOFT – Product Status 37

ART FILLER LIPS SOFT – Product Description 38

ART FILLER UNIVERSAL – Product Status 38

ART FILLER UNIVERSAL – Product Description 38

ART FILLER VOLUME – Product Status 39

ART FILLER VOLUME – Product Description 39

NCTF 135 – Product Status 39

NCTF 135 – Product Description 40

NCTF 135 HA – Product Status 40

NCTF 135 HA – Product Description 40

Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview 41

Prevelle Lift – Product Status 41

Prevelle Lift – Product Description 41

Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

BiOLinkMatrix Gel – Product Status 42

BiOLinkMatrix Gel – Product Description 42

Hyaluronic Acid Dermal Filler – Product Status 43

Hyaluronic Acid Dermal Filler – Product Description 43

Hallura Ltd – Ongoing Clinical Trials Overview 44

BiOLinkMatrix Gel – Prospective, Interventional, Non-randomized, Open Label Study for the Evaluation of the Safety and Performance of an Injectable Hyaluronic Acid Filler 45

Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview 46

The Chaeum Pure No.1 – Product Status 46

The Chaeum Pure No.1 – Product Description 47

The Chaeum Pure No.2 – Product Status 47

The Chaeum Pure No.2 – Product Description 47

The Chaeum Pure No.3 – Product Status 48

The Chaeum Pure No.3 – Product Description 48

The Chaeum Pure No.4 – Product Status 48

The Chaeum Pure No.4 – Product Description 49

The Chaeum Style – Product Status 49

The Chaeum Style – Product Description 49

LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

LR19093 – Product Status 50

LR19093 – Product Description 50

LR20024 – Product Status 51

LR20024 – Product Description 51

YVOIRE Y-Solution 360 – Product Status 51

YVOIRE Y-Solution 360 – Product Description 52

YVOIRE Y-Solution 540 – Product Status 52

YVOIRE Y-Solution 540 – Product Description 52

YVOIRE Y-Solution 720 – Product Status 53

YVOIRE Y-Solution 720 – Product Description 53

LG Chem Ltd – Ongoing Clinical Trials Overview 54

YVOIRE Y-Solution 360 – A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer 55

YVOIRE Y-Solution 360 – A Multicenter, Randomized, Rater-Blinded, No-Treatment Control Design Clinical Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 360 for Lip Augmentation 55

YVOIRE Y-Solution 540 – A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer 56

YVOIRE Y-Solution 540 – A Randomized, Multicenter, Evaluator-blinded, Active-controlled, Parallel-group Design Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 540 Versus YVOIRE Volume Plus in Nasolabial Folds Injection 56

YVOIRE Y-Solution 720 – A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer 57

YVOIRE Y-Solution 720 – A Multicenter, Randomized, Evaluator-blinded, No-treatment Control Design Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected for Jawline Contouring 57

YVOIRE Y-Solution 720 – A Multicenter, Randomized, Rater-blinded, No-treatment Control Design Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-face 57

LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview 58

Lumina – Product Status 58

Lumina – Product Description 58

LifeSprout Inc – Ongoing Clinical Trials Overview 59

Lumina – A Prospective, Randomized, Controlled, Multi-center Study of the Safety and Effectiveness of Lumina in the Treatment of Nasolabial Folds 60

Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview 61

Neuramis Deep Lidocaine – Product Status 61

Neuramis Deep Lidocaine – Product Description 61

Neuramis Volume Lidocaine – Product Status 62

Neuramis Volume Lidocaine – Product Description 62

Merz North America Inc Pipeline Products & Ongoing Clinical Trials Overview 63

VP1 Lido US – Product Status 63

VP1 Lido US – Product Description 63

Merz North America Inc – Ongoing Clinical Trials Overview 64

VP1 Lido US – A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of VP1 Lido US for Volume Augmentation of the Cheek 65

Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview 66

mRDX-02-17 – Product Status 66

mRDX-02-17 – Product Description 66

Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview 67

AntaRep – Product Status 67

AntaRep – Product Description 67

Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview 68

GAL1906 – Product Status 68

GAL1906 – Product Description 68

Q-Med AB – Ongoing Clinical Trials Overview 69

GAL1906 – A Randomized, Evaluator-blinded, No-treatment Controlled, Multicenter Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area 70

Revance Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 71

RHA Redensity – Product Status 71

RHA Redensity – Product Description 71

Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 72

QST Gel – Product Status 72

QST Gel – Product Description 72

Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 73

FreeWink – Product Status 73

FreeWink – Product Description 73

Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 74

Dermal Filler – Product Status 74

Dermal Filler – Product Description 74

SMA-001 – Product Status 75

SMA-001 – Product Description 75

Silk Medical Aesthetics Inc – Ongoing Clinical Trials Overview 76

Dermal Filler – A Feasibility Clinical Trial of All-natural Dermal Filler for Nasolabial Folds 77

Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 78

Atlean – Product Status 78

Atlean – Product Description 78

MaiLi – Product Status 79

MaiLi – Product Description 79

Perfectha G – Product Status 79

Perfectha G – Product Description 80

Perfectha Lips – Product Status 80

Perfectha Lips – Product Description 80

Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview 81

Teosyal RHA 1 – Product Status 81

Teosyal RHA 1 – Product Description 81

Teoxane SA – Ongoing Clinical Trials Overview 82

Teosyal RHA 1 – A Prospective, Multicentric, Open-labelled, Interventional Study to Assess Skin Beautification by Treating Fine Lines in the Neck, Perioral and Smiling Lines Areas With TEOSYAL RHA 1 83

Teosyal RHA 1 – A Prospective, Single Blind, Single-center Study Evaluating the Histology and Intradermal Implantation of the Teosyal RHA Collection of Fillers 83

Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview 84

PureVoluma – Product Status 84

PureVoluma – Product Description 84

Glossary 88

List of Figures

Hyaluronic Acid Fillers – Pipeline Products by Stage of Development 11

Hyaluronic Acid Fillers – Pipeline Products by Segment 12

Hyaluronic Acid Fillers – Pipeline Products by Territory 13

Hyaluronic Acid Fillers – Pipeline Products by Regulatory Path 14

Hyaluronic Acid Fillers – Pipeline Products by Estimated Approval Date 15

Hyaluronic Acid Fillers – Ongoing Clinical Trials 16

Frequently Asked Questions

Request a Free Sample
$4000

Can be used by individual purchaser only

$12000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.